ST-617 HEAD and NECK

As you are going to be treated with chemoradiation therapy for your head and neck cancer, you will most likely develop oral mucositis. As such this study is testing an experimental treatment for oral mucositis. This experimental treatment is called ST-617.

Acronym:

ST 617-101

ACTRN/NCT /ethics:

ACTRN12620000541909

Scientific title:

A Phase 1b, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ST-617 for the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for Head and Neck Cancer

Sponsor / Cooperative group:

Supportive Therapeutics (Pty) Ltd